Staats HF - Search Results

1

The V3 domain of SIVmac251 gp120 contains a linear neutralizing epitope.

Palker TJ, Muir AJ, Spragion DE, Staats HF, Langlois A, Montefiori DC. Palker TJ, et al. Among authors: staats hf. Virology. 1996 Oct 15;224(2):415-26. doi: 10.1006/viro.1996.0548. Virology. 1996. PMID: 8874502 Free article.

2

Effect of bismuth salts on systemic and mucosal immune responses to orally administered cholera toxin.

Horowitz NS, Staats HF, Palker TJ. Horowitz NS, et al. Among authors: staats hf. Immunopharmacology. 1995 Nov;31(1):31-41. doi: 10.1016/0162-3109(95)00031-2. Immunopharmacology. 1995. PMID: 8655289

3

Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A).

Staats HF, Nichols WG, Palker TJ. Staats HF, et al. J Immunol. 1996 Jul 1;157(1):462-72. J Immunol. 1996. PMID: 8683152

4

Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo.

Porgador A, Staats HF, Faiola B, Gilboa E, Palker TJ. Porgador A, et al. Among authors: staats hf. J Immunol. 1997 Jan 15;158(2):834-41. J Immunol. 1997. PMID: 8993001

5

Intranasal immunization is superior to vaginal, gastric, or rectal immunization for the induction of systemic and mucosal anti-HIV antibody responses.

Staats HF, Montgomery SP, Palker TJ. Staats HF, et al. AIDS Res Hum Retroviruses. 1997 Jul 20;13(11):945-52. doi: 10.1089/aid.1997.13.945. AIDS Res Hum Retroviruses. 1997. PMID: 9223410

6

HIV vaccine development at Duke University Medical Center.

Haynes BF, Liao HX, Staats HF, Alam MS, Weinhold KJ, Montefiori DC. Haynes BF, et al. Among authors: staats hf. Immunol Res. 2000;22(2-3):263-9. doi: 10.1385/ir:22:2-3:263. Immunol Res. 2000. PMID: 11339361 Review.

7

Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin G (IgG) and IgA antibodies in serum and mucosal secretions after nasal immunization.

Bradney CP, Sempowski GD, Liao HX, Haynes BF, Staats HF. Bradney CP, et al. Among authors: staats hf. J Virol. 2002 Jan;76(2):517-24. doi: 10.1128/jvi.76.2.517-524.2002. J Virol. 2002. PMID: 11752142 Free PMC article.

8

Increased immunogenicity of HIV envelope subunit complexed with alpha2-macroglobulin when combined with monophosphoryl lipid A and GM-CSF.

Liao HX, Cianciolo GJ, Staats HF, Scearce RM, Lapple DM, Stauffer SH, Thomasch JR, Pizzo SV, Montefiori DC, Hagen M, Eldridge J, Haynes BF. Liao HX, et al. Among authors: staats hf. Vaccine. 2002 May 22;20(17-18):2396-403. doi: 10.1016/s0264-410x(02)00090-7. Vaccine. 2002. PMID: 12009296

9

A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques.

Egan MA, Chong SY, Hagen M, Megati S, Schadeck EB, Piacente P, Ma BJ, Montefiori DC, Haynes BF, Israel ZR, Eldridge JH, Staats HF. Egan MA, et al. Among authors: staats hf. Vaccine. 2004 Sep 9;22(27-28):3774-88. doi: 10.1016/j.vaccine.2004.03.011. Vaccine. 2004. PMID: 15315859

10

Gender differences in human immunodeficiency virus type 1-specific CD8 responses in the reproductive tract and colon following nasal peptide priming and modified vaccinia virus Ankara boosting.

Peacock JW, Nordone SK, Jackson SS, Liao HX, Letvin NL, Yafal AG, Gritz L, Mazzara GP, Haynes BF, Staats HF. Peacock JW, et al. Among authors: staats hf. J Virol. 2004 Dec;78(23):13163-72. doi: 10.1128/JVI.78.23.13163-13172.2004. J Virol. 2004. PMID: 15542668 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page